These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28067669)

  • 21. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.
    Ravel-Chapuis A; Bélanger G; Côté J; Michel RN; Jasmin BJ
    Hum Mol Genet; 2017 Jun; 26(12):2192-2206. PubMed ID: 28369518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.
    Benziane B; Björnholm M; Pirkmajer S; Austin RL; Kotova O; Viollet B; Zierath JR; Chibalin AV
    J Biol Chem; 2012 Jul; 287(28):23451-63. PubMed ID: 22610379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
    Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
    J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of Scn5a mis-splicing does not improve the structural and functional heart defects of a DM1 heart mouse model.
    Nitschke L; Hu RC; Miller AN; Cooper TA
    Hum Mol Genet; 2024 Oct; 33(20):1789-1799. PubMed ID: 39126705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
    Li C; Reif MM; Craige SM; Kant S; Keaney JF
    Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
    Loro E; Rinaldi F; Malena A; Masiero E; Novelli G; Angelini C; Romeo V; Sandri M; Botta A; Vergani L
    Cell Death Differ; 2010 Aug; 17(8):1315-24. PubMed ID: 20431600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
    Guo D; Hildebrandt IJ; Prins RM; Soto H; Mazzotta MM; Dang J; Czernin J; Shyy JY; Watson AD; Phelps M; Radu CG; Cloughesy TF; Mischel PS
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12932-7. PubMed ID: 19625624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
    Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
    J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
    Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W
    Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
    Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
    Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
    Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.
    Habib SL; Yadav A; Kidane D; Weiss RH; Liang S
    Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.
    Davis B; Rahman A; Arner A
    Eur J Pharmacol; 2012 Nov; 695(1-3):88-95. PubMed ID: 22921370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
    Rothbart SB; Racanelli AC; Moran RG
    Cancer Res; 2010 Dec; 70(24):10299-309. PubMed ID: 21159649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.
    Pandey SK; Wheeler TM; Justice SL; Kim A; Younis HS; Gattis D; Jauvin D; Puymirat J; Swayze EE; Freier SM; Bennett CF; Thornton CA; MacLeod AR
    J Pharmacol Exp Ther; 2015 Nov; 355(2):329-40. PubMed ID: 26330536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
    Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
    Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.